-
Healthcare Resource Utilization and Cost Comparison Between Palbociclib, Abemaciclib, and Ribociclib Among Patients with HR+/HER2− Metastatic Breast Cancer
25 Mar 2025 19:05 GMT
… for advanced breast cancer. NPJ Breast Cancer. 2019;5 … HER2-negative metastatic breast cancer. NPJ Breast Cancer. 2023;9( … letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer … 47;HER2- metastatic breast cancer. NPJ Breast Cancer. 2022;8( …
-
Easing Patients Beyond Panic in Metastatic Breast Cancer
25 Mar 2025 15:42 GMT
… in the setting of metastatic breast cancer. And in your situation … first diagnosed with metastatic breast cancer, which is honestly a … said women with metastatic breast cancer live many, many years … using a hormone medicine, letrozole, and a targeted medicine …
-
Selection of Frontline CDK4/6 Inhibitors Hinges on Patient Health Status in HR+/HER2– Metastatic Breast Cancer
21 Mar 2025 20:19 GMT
… )–positive, HER2-negative metastatic breast cancer setting, frontline treatment with CDK4 … HR-positive, HER2-negative metastatic breast cancer, considerations when selecting optimal … Survival with Ribociclib plus Letrozole in Advanced Breast Cancer. N Engl J …
-
The Safety and Efficacy of Anticancer Therapy in Breast Cancer Patients with Liver Cirrhosis
19 Mar 2025 11:08 GMT
… therapy, endocrine therapy (letrozole) only, and other therapy … liver metastasis.
Abbreviations
BC, breast cancer; LC, liver cirrhosis; … and BRCA2-associated breast cancer. Breast Cancer Res Treat. 2016 … targeted therapy for breast cancer patients with …
-
Escalation and De-Escalation Strategies for Endocrine Therapy in Early-Stage Breast Cancer
13 Mar 2025 07:55 GMT
… /HER2-negative breast cancers with very small (T1a … elderly patients with breast cancer.
The Breast Cancer Index (BCI) … with palbociclib plus letrozole in advanced breast cancer. J Clin Oncol … T1a/bN0M0 breast cancer. Breast Cancer Res Treat. 2023; …
-
Sexual Health Considerations to Improve Survivorship in Breast Cancer
11 Mar 2025 22:37 GMT
… use of anastrozole, letrozole, and exemestane block … commonly, women with breast cancer who experienced early … breast cancer. Presented at the 2025 Miami Breast Cancer Conference … in hormone-sensitive breast cancer. Living Beyond Breast Cancer. News release …
-
Atirmociclib Plus Letrozole Demonstrates Preliminary Efficacy and Safety in HR+/HER2-Negative Metastatic Breast Cancer
10 Mar 2025 21:29 GMT
… HER2-negative metastatic breast cancer. Data from the … 42nd Annual Miami Breast Cancer Conference.
Findings … letrozole in patients with HR-positive, HER2-negative metastatic breast cancer … metastatic breast cancer. Presented at: 42nd Annual Miami Breast Cancer …
-
SERDs, PROTAC, and CERANs Offer Hope Following ET/CDK4/6 Inhibitor Resistance in Breast Cancer
10 Mar 2025 21:28 GMT
… with palbociclib and letrozole. The phase … breast cancer. Presented at: 42nd Annual Miami Breast Cancer … breast cancer (mBC). Presented at: 2024 San Antonio Breast Cancer … metastatic breast cancer. Presented at: 2024 San Antonio Breast Cancer Symposium …
-
Alisertib Plus Endocrine Therapy Is Under Evaluation in HR+/HER2-Negative Metastatic Breast Cancer
10 Mar 2025 21:26 GMT
… recurrent or metastatic breast cancer previously treated with … endocrine-resistant metastatic breast cancer, the overall response … recurrent or metastatic breast cancer not amenable to … anastrozole, exemestane, fulvestrant, letrozole, or tamoxifen. Treatment …
-
Immunotherapies Spark Excitement in Triple-Negative Breast Cancer Treatment
08 Mar 2025 13:21 GMT
… breast cancer, and Komen Distinguished Chair in Clinical Breast Cancer … chemotherapy (82%) and letrozole (Femara; 18%) in the … breast cancer. Presented at: 2024 San Antonio Breast Cancer … breast cancer (TNBC). Presented at: 2024 San Antonio Breast Cancer …
About
© 1995-2025